Arbutus Biopharma Corp. (ABUS)
4.45
-0.11
(-2.41%)
USD |
NASDAQ |
Oct 02, 16:00
4.475
+0.02
(+0.56%)
After-Hours: 20:00
Arbutus Biopharma Profit Margin (Quarterly) : -507.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -507.2% |
| March 31, 2026 | 94.74% |
| December 31, 2025 | -357.4% |
| September 30, 2025 | -1.46K% |
| June 30, 2025 | 23.49% |
| March 31, 2025 | -1.39K% |
| December 31, 2024 | -796.2% |
| September 30, 2024 | -1.47K% |
| June 30, 2024 | -1.15K% |
| March 31, 2024 | -1.17K% |
| December 31, 2023 | -900.3% |
| September 30, 2023 | -431.6% |
| June 30, 2023 | -367.5% |
| March 31, 2023 | -244.3% |
| December 31, 2022 | -351.2% |
| September 30, 2022 | -295.1% |
| June 30, 2022 | -99.66% |
| March 31, 2022 | -125.3% |
| December 31, 2021 | -665.0% |
| September 30, 2021 | -573.6% |
| June 30, 2021 | -832.4% |
| March 31, 2021 | -775.2% |
| December 31, 2020 | -714.2% |
| September 30, 2020 | -1.23K% |
| June 30, 2020 | -930.4% |
| Date | Value |
|---|---|
| March 31, 2020 | -929.6% |
| December 31, 2019 | -1.52K% |
| September 30, 2019 | -2.70K% |
| June 30, 2019 | -3.57K% |
| March 31, 2019 | -3.42K% |
| December 31, 2018 | -1.09K% |
| September 30, 2018 | -1.54K% |
| June 30, 2018 | |
| March 31, 2018 | -1.21K% |
| December 31, 2017 | -1.42K% |
| September 30, 2017 | -168.3% |
| June 30, 2017 | -1.76K% |
| March 31, 2017 | -7.93K% |
| December 31, 2016 | |
| September 30, 2016 | -2.53K% |
| June 30, 2016 | -42.07K% |
| March 31, 2016 | -2.63K% |
| December 31, 2015 | -41.49% |
| September 30, 2015 | -713.0% |
| June 30, 2015 | -432.7% |
| March 31, 2015 | -256.1% |
| December 31, 2014 | -141.8% |
| September 30, 2014 | -197.2% |
| June 30, 2014 | -335.8% |
| March 31, 2014 | -406.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Insmed, Inc. | -3.11% |
| Pfizer Inc. | -1.64% |
| Gossamer Bio, Inc. | -- |
| Legend Biotech Corp. | 8.57% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 101.2% |
| Return on Assets | 90.37% |
| Return on Invested Capital | 98.47% |
| Gross Profit Margin (Quarterly) | 98.92% |
| Operating Margin (Quarterly) | -567.2% |
| Return on Net Operating Assets | 14.15K% |